作者: Elliott M. Antman , John D. Rutherford
DOI: 10.1007/978-1-4613-2303-7_13
关键词: Internal medicine 、 Creatine kinase 、 Myocardial infarction 、 Cardiology 、 Thrombolytic Agent 、 Limiting 、 Size reduction 、 Logical approach 、 Functional integrity 、 Infarct size 、 Medicine
摘要: In 1912, Herrick concluded his classic article by presenting a logical approach to the treatment of myocardial infarction: “the hope for damaged myocardium lies in direction securing supply blood through friendly neighbouring vessels so as restore far possible its functional integrity” [1]. Thus, this distinguished physician anticipated more than half century concept limiting infarct size.